Polymorphisms of genes in nitric oxide-forming pathway associated with ischemic stroke in Chinese Han population

被引:16
作者
Yan, Jiang-tao [1 ,2 ]
Zhang, Lan [1 ,2 ]
Xu, Yu-jun [1 ]
Wang, Xiao-jing [3 ]
Wang, Cong-yi [4 ]
Wang, Dao-wen [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430030, Peoples R China
[3] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15219 USA
[4] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA
关键词
ischemic stroke; nitric oxide; polymorphism; genetics; Chinese Han population; CORONARY-ARTERY-DISEASE; SYNTHASE GENE; P22PHOX GENE; HPH-1; MOUSE; EXON; 7; RISK; TETRAHYDROBIOPTERIN; SUPEROXIDE; VARIANT; GTP;
D O I
10.1038/aps.2011.114
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To investigate the association of polymorphisms in four critical genes implicated in the NO-forming pathway with ischemic stroke (IS) in a Chinese Han population. Methods: DNA samples of 558 IS patients and 557 healthy controls from Chinese Han population were genotyped using the Taqman (TM) 7900HT Sequence Detection System. Six SNPs (rs841, rs1049255, rs2297518, rs1799983, rs2020744, rs4673) of the 4 related genes (eNOS, iNOS, GCH1, and CYBA) in the NO forming pathway were analyzed using the SPSS 13.0 software package for Windows. Results: One SNP located in the intron of GCH1 (rs841) was associated with IS independent of the traditional cardiovascular risk factors in co-dominant and dominant models (P=0.003, q=0.027; P=0.00006, q=0.0108; respectively). Moreover, the combination of rs1049255 CC+CT and rs841 GA+AA genotypes was associated with significantly higher risk for IS after adjustments (OR=1.73, 95% CI: 1.27-2.35, P<0.0001, q<0.0001). Conclusion: The data suggest that genetic variants within the NO-forming pathway alter susceptibility to IS in Chinese Han population. Replication of the present results in other independent cohorts is warranted.
引用
收藏
页码:1357 / 1363
页数:7
相关论文
共 32 条
[11]   The HPH-1 mouse:: A model for dominantly inherited GTP-cyclohydrolase deficiency [J].
Hyland, K ;
Gunasekara, RS ;
Munk-Martin, TL ;
Arnold, LA ;
Engle, T .
ANNALS OF NEUROLOGY, 2003, 54 :S46-S48
[12]   NITRIC-OXIDE SYNTHASE INHIBITION AND CEREBROVASCULAR REGULATION [J].
IADECOLA, C ;
PELLIGRINO, DA ;
MOSKOWITZ, MA ;
LASSEN, NA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (02) :175-192
[13]   Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease [J].
Inoue, N ;
Kawashima, S ;
Kanazawa, K ;
Yamada, S ;
Akita, H ;
Yokoyama, M .
CIRCULATION, 1998, 97 (02) :135-137
[14]   Stroke in China [J].
Jia, Qian ;
Liu, Li-Ping ;
Wang, Yong-Jun .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (02) :259-264
[15]   NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases [J].
Jose, Gorka San ;
Fortuno, Ana ;
Beloqui, Oscar ;
Diez, Javier ;
Zalba, Guillermo .
CLINICAL SCIENCE, 2008, 114 (3-4) :173-182
[16]   Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension [J].
Khoo, JP ;
Zhao, L ;
Alp, NJ ;
Bendall, JK ;
Nicoli, T ;
Rockett, K ;
Wilkins, MR ;
Channon, KM .
CIRCULATION, 2005, 111 (16) :2126-2133
[17]   Congenic mapping and genotyping of the tetrahydrobiopterin-deficient hph-1 mouse [J].
Khoo, JP ;
Nicoli, T ;
Alp, NJ ;
Fullerton, J ;
Flint, J ;
Channon, KM .
MOLECULAR GENETICS AND METABOLISM, 2004, 82 (03) :251-254
[18]  
Li A, 1999, AM J MED GENET, V86, P57, DOI 10.1002/(SICI)1096-8628(19990903)86:1<57::AID-AJMG11>3.0.CO
[19]  
2-R
[20]   Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma [J].
Markus, HS ;
Ruigrok, Y ;
Ali, N ;
Powell, JF .
STROKE, 1998, 29 (09) :1908-1911